Definitive Healthcare Corp.

DHNASDAQHealthcare● Active

$0.90

$-0.01(-1.14%)

Market Cap$94655241

P/E Ratio—

52W High$4.7

52W Low$0.803

Avg Volume331K

Open$0.91

Beta1.33

Free Cash Flow Financials Revenue

Definitive Healthcare Corp. (DH) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

DH · free cash flow · updated Jun 8, 2026

Core FCF metrics

DH · FCF · TTM · margin & CAGR

Free cash flow was $37.1M for FY2025 (fiscal year ending 2025-12-31), down 19.2% year-over-year The FCF margin was 15.3%. Five-year CAGR stands at +11.2%.

FY2025 Free Cash Flow$37.1M▼ -19.2% YoY

Trailing 12M (TTM)$37.1Mtrailing 4 quarters sum

FCF Margin15.3%$37.1M ÷ revenue

3-Year CAGR+10.8%FY2022 → FY2025

5-Year CAGR+11.2%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

DH · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$53.8M(17M)$37.1M▼ 19.2%15.3%

FY2024$58.2M(12M)$45.9M▲ +20.0%18.2%

FY2023$41.2M(3M)$38.2M▲ +40.2%15.2%

FY2022$35.6M(8M)$27.3M▲ +47.5%12.2%

FY2021$25.2M(7M)$18.5M▼ 15.3%11.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

DH · P/FCF · FCF yield · FCF per share

Definitive Healthcare Corp. (DH) trades at a FCF yield of 39.15% and a price-to-free-cash-flow ratio of 2.6x. FCF per share stands at $0.35, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

39.15%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.35

TTM FCF ÷ Shares Outstanding

Price / FCF

x2.6

Share Price ÷ FCF per Share

EV / FCF (TTM)

x2.9

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

DH · cash flow statement · operating / investing / financing

For FY2025, Definitive Healthcare Corp. generated $53.8M in operating cash flow and spent 17M in capital expenditures, yielding $37.1M in free cash flow.

Operating Activities

+$53.8M

Cash from core business operations

2025-12-31

Investing Activities

+$153.9M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$150.8M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($53.8M) − |CapEx| (17M) = FCF ($37.1M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

DH vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Definitive Healthcare Corp.YOU

$37.1M-19.2%15.3%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Definitive Healthcare Corp. (DH) reported free cash flow of $37.1M for FY2025 (fiscal year ending 2025-12-31), down 19.2% year-over-year. The FCF margin was 15.3%.

Based on available data, Definitive Healthcare Corp. has maintained positive free cash flow for at least 7 fiscal year(s). FCF peaked at $45.9M in FY2024. The 5-year CAGR stands at +11.2%.

Definitive Healthcare Corp.'s FCF yield is 39.15% and price-to-FCF ratio is 2.6x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

DH free cash flow · 8 questions

Definitive Healthcare Corp. free cash flow was $37.1M for FY2025, down 19.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $37.1M.

DH free cash flowDH FCFDH FCF 2025DH free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Definitive Healthcare Corp. · Definitive Healthcare Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026